Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Miller Thomson LLP
Health Canada is seeking input about new nutrition labelling requirements for Canada.
Blake, Cassels & Graydon LLP
Last month, the Government of Canada launched a series of public consultations regarding proposed changes to the federal nutrition labelling requirements.
Norton Rose Fulbright Canada LLP
The policy aims to prevent medication errors that can occur in practice given similarity between product names.
Gowling Lafleur Henderson LLP
The Heart and Stroke Foundation (the "Foundation") recently announced the end of their popular "Health Check" program after 15 years in the marketplace.
Miller Thomson LLP
As of August 21, 2014, mechanically tenderized beef sold in Canada must be labelled to identify that it has been subject to this processing, as well as to provide safe cooking instructions.
Norton Rose Fulbright Canada LLP
On July 22, 2014, Ontario’s Minister of Health and Long-Term Care introduced Bill 21, Safeguarding Health Care Integrity Act, 2014.
Norton Rose Fulbright Canada LLP
Last year, M&A activity in the U.S. healthcare and life sciences sector saw a decrease in both deal number and deal value when compared with 2012.
MNP
In a context of weak growth, consolidation and maturity (see previous blog: Dynamics of the food and beverage manufacturing sector in Quebec: the retailer perspective), what are retailers doing to differentiate themselves and address their shareholders’ concerns?
Torys LLP
On June 16, 2014, amendments to Bill C-17, Protecting Canadians from Unsafe Drugs Act (the Bill), were announced.
McCarthy Tétrault LLP
On June 20, 2014, the B.C. Government announced a host of new liquor laws that will be of interest to B.C. employers.
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Norton Rose Fulbright Canada LLP
Bill C-17, An Act to Amend the Food and Drugs Act, was introduced into Parliament by the Minister of Health on December 6, 2013.
Borden Ladner Gervais LLP
Currently, a community care access centre is defined as an approved agency that provides homemaking, personal support and professional services.
Gowling Lafleur Henderson LLP
"Personalized medicine," in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs and preferences.
Borden Ladner Gervais LLP
While overall venture capital financing in Canada is on the rise compared to past years, life science start-ups are not experiencing the same increase.
Borden Ladner Gervais LLP
Canada has a regulatory regime that can affect the pricing of both small molecule and biologic medicines.
Borden Ladner Gervais LLP
In Canada, the sale and marketing of pharmaceuticals, biologics, medical devices and other healthcare products are regulated under the Food & Drugs Act.
Norton Rose Fulbright Canada LLP
In July 2013, new regulations relating to the use and production of medical marihuana came into force. The Marihuana for Medical Purposes Regulations (MMPR) significantly overhaul the previous statutory regime regulating medical marihuana in Canada.
MNP
When you pick up a newspaper, you’re bound to find something related to Canada’s or a specific province or territory’s health system.
Borden Ladner Gervais LLP
Canadian examiners’ objections to claims in which the examiner argues that there is not full support for the claims in the description have become increasingly common.
Latest Video
Most Popular Recent Articles
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Davis LLP
As you’re probably already well aware, the government of BC has been undergoing its first major review of our antiquated liquor laws in over two decades.
Bereskin & Parr LLP
Typically, the threshold of utility is easily met for inventions that have commercial applicability, such as a drug candidate.
McCarthy Tétrault LLP
Justice Roger T. Hughes granted AbbVie the first-ever limited injunction against a branded pharmaceutical company infringing a branded competitor’s patent.
Torys LLP
On July 2, 2014, the Federal Court released its trial decision on the validity of the patent for esomeprazole, a proton pump inhibitor.
MNP
Over the last decade the federal government has introduced legislation allowing medical doctors in Canada to incorporate.
Norton Rose Fulbright Canada LLP
Last year, M&A activity in the U.S. healthcare and life sciences sector saw a decrease in both deal number and deal value when compared with 2012.
Miller Thomson LLP
On March 24, 2014, we introduced readers to Bill 179, the Public Sector and MPP Accountability and Transparency Act, 2014, for first reading by lawmakers.
Stikeman Elliott LLP
Justice Bracken of the British Columbia Supreme Court dismissed a proposed class action against two generic manufacturers of transdermal fentanyl patches.
Norton Rose Fulbright Canada LLP
The policy aims to prevent medication errors that can occur in practice given similarity between product names.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners